ROS-Responsive Hydrogel for Spatiotemporal Cascade Regulation of Ferroptosis and Fibrosis for Myocardial Protection
ACS Applied Materials & Interfaces · 04.11.2026 · 18 (43) · 59952-59969
DOI: 10.1021/acsami.6c15728 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 20.10.2026. Verfasst von Shaodong Zhai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital , Taiyuan030032, Chi…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Myocardial Infarction, Ferroptosis, Hydrogels. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Shanxi Province, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Myocardial infarction (MI)-induced cardiac injury is mainly divided into two phases: the acute necrotic phase and the repair phase. Given the distinct therapeutic requirements of each phase—salvaging dying cardiomyocytes and reducing infarct size in the acute phase, while achieving controlled fibrosis to promote effective ventricular remodeling in the repair phase—we designed an ROS-responsive hydrogel co-delivery system (Met/Anti-34a@Gel) loaded with metformin (Met) and Anti-34a liposomes (Anti-34a Lip) to achieve precise regulation of both the acute and repair phases of MI. In the highly oxidative stress microenvironment following MI, the hydrogel gradually degrades and releases Met and Anti-34a Lip in a stage-specific manner. Met improves mitochondrial function, inhibits oxidative stress and ferroptosis, thereby effectively salvaging cardiomyocytes in the acute phase. Anti-34a Lip modulates the differentiation behavior of cardiac fibroblasts, suppressing excessive fibrosis and promoting favorable ventricular remodeling in the repair phase. Echocardiography revealed that Met/Anti-34a@Gel preserved left ventricular ejection fraction (EF) and fractional shortening (FS) at 72 h post-MI, reduced serum MDA levels in the acute phase, and maintained EF at approximately 60.92 ± 8.37% with a lower collagen I/III ratio at 4 weeks, collectively demonstrating both acute cardioprotection and long-term anti-fibrotic remodeling. In this combined therapeutic strategy, the early mitochondrial protection and anti-ferroptosis effects establish a favorable tissue and functional foundation for subsequent precision anti-fibrotic therapy, while the later anti-fibrotic treatment further consolidates the early protective effects. The two actions synergistically form a positive feedback loop, ultimately achieving sustained long-term cardiac functional improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital , Taiyuan030032, China.
- School of Basic Medical Science, Shanxi Medical University, Taiyuan030001, China.
- Department of Radiology, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan030001, China.
ORCID-Profile: Shaodong Zhai, Ruiping Zhang
Förderung
- Natural Science Foundation of Shanxi Province
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhai, S., Wang, Z., Wang, J., Guo, X., Tan, X., Zhang, H., Zhang, R., & Hu, N. (2026). ROS-Responsive Hydrogel for Spatiotemporal Cascade Regulation of Ferroptosis and Fibrosis for Myocardial Protection. ACS Applied Materials & Interfaces, 18(43), 59952-59969. https://doi.org/10.1021/acsami.6c15728
Vancouver
Zhai S, Wang Z, Wang J, Guo X, Tan X, Zhang H, et al. ROS-Responsive Hydrogel for Spatiotemporal Cascade Regulation of Ferroptosis and Fibrosis for Myocardial Protection. ACS Applied Materials & Interfaces. 2026;18(43):59952-59969. doi:10.1021/acsami.6c15728
BibTeX
@article{Zhai2026,
author = {Zhai, Shaodong and Wang, Zhenghao and Wang, Jing and Guo, Xiang and Tan, Xiao and Zhang, Hongnv and Zhang, Ruiping and Hu, Nan},
title = {ROS-Responsive Hydrogel for Spatiotemporal Cascade Regulation of Ferroptosis and Fibrosis for Myocardial Protection},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {43},
pages = {59952--59969},
doi = {10.1021/acsami.6c15728}
}
EUVIMED